Dennis Langer - Net Worth and Insider Trading
Dennis Langer Net Worth
The estimated net worth of Dennis Langer is at least $5 Million dollars as of 2024-09-20. Dennis Langer is the Director of Dicerna Pharmaceuticals Inc and owns about 77,042 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $3 Million. Dennis Langer is the Director of Myriad Genetics Inc and owns about 89,527 shares of Myriad Genetics Inc (MYGN) stock worth over $3 Million. Dennis Langer is also the Director of Quoin Pharmaceuticals Ltd and owns about 53 shares of Quoin Pharmaceuticals Ltd (QNRX) stock worth over $30. Details can be seen in Dennis Langer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis Langer has not made any transactions after 2024-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis Langer
Dennis Langer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Langer owns 7 companies in total, including Myriad Genetics Inc (MYGN) , Dicerna Pharmaceuticals Inc (DRNA) , and Pernix Therapeutics Holdings Inc (PTXTQ) among others .
Click here to see the complete history of Dennis Langer’s form 4 insider trades.
Insider Ownership Summary of Dennis Langer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MYGN | Myriad Genetics Inc | 2021-08-03 | director |
| DRNA | Dicerna Pharmaceuticals Inc | 2019-06-20 | director |
| PTXTQ | Pernix Therapeutics Holdings Inc | 2018-05-22 | director |
 | | 2015-06-10 | director |
| | 2011-12-08 | director |
| | 2021-05-01 | director |
| | 2024-06-07 | director |
Dennis Langer Latest Holdings Summary
Dennis Langer currently owns a total of 3 stocks. Among these stocks, Dennis Langer owns 77,042 shares of Dicerna Pharmaceuticals Inc (DRNA) as of August 15, 2018, with a value of $3 Million and a weighting of 53.73%. Dennis Langer owns 89,527 shares of Myriad Genetics Inc (MYGN) as of August 3, 2021, with a value of $3 Million and a weighting of 46.27%. Dennis Langer also owns 53 shares of Quoin Pharmaceuticals Ltd (QNRX) as of June 7, 2024, with a value of $30 and a weighting of 0%.
Latest Holdings of Dennis Langer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2018-08-15 | 77,042 | 38.22 | 2,944,545 |
| MYGN | Myriad Genetics Inc | 2021-08-03 | 89,527 | 28.32 | 2,535,405 |
| QNRX | Quoin Pharmaceuticals Ltd | 2024-06-07 | 53 | 0.58 | 30 |
Holding Weightings of Dennis Langer
Dennis Langer Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Langer has made a total of 0 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 38,341 shares on August 15, 2018, which brought Dennis Langer around $613,456.
According to the SEC Form 4 filings, Dennis Langer has made a total of 1 transactions in Myriad Genetics Inc (MYGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Myriad Genetics Inc is the sale of 30,000 shares on August 3, 2021, which brought Dennis Langer around $1 Million.
According to the SEC Form 4 filings, Dennis Langer has made a total of 1 transactions in Quoin Pharmaceuticals Ltd (QNRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Quoin Pharmaceuticals Ltd is the sale of 297 shares on June 7, 2024, which brought Dennis Langer around $217.
Insider Trading History of Dennis Langer
- 1
Dennis Langer Trading Performance
Dennis Langer Ownership Network
Dennis Langer Owned Company Details
What does Myriad Genetics Inc do?
Who are the key executives at Myriad Genetics Inc?
Dennis Langer is the director of Myriad Genetics Inc. Other key executives at Myriad Genetics Inc include Chief Scientific Officer Dale Muzzey , director & President and CEO Paul J Diaz , and SVP & Chief of Staff Margaret Ancona .
Myriad Genetics Inc (MYGN) Insider Trades Summary
Over the past 18 months, Dennis Langer made no insider transaction in Myriad Genetics Inc (MYGN). Other recent insider transactions involving Myriad Genetics Inc (MYGN) include a net sale of 242,844 shares made by Paul J Diaz , a net sale of 60,000 shares made by Richard Bryan Riggsbee , and a net sale of 16,214 shares made by Daniel K Spiegelman .
In summary, during the past 3 months, insiders sold 92,150 shares of Myriad Genetics Inc (MYGN) in total and bought 0 shares, with a net sale of 92,150 shares. During the past 18 months, 408,841 shares of Myriad Genetics Inc (MYGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 408,841 shares.
Myriad Genetics Inc (MYGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myriad Genetics Inc Insider Transactions
Dennis Langer Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Langer. You might contact Dennis Langer via mailing address: C/o Peter Tsoflias, Blank Rome Llp, One Logan Square, Fl 9, Philadelpha Pa 19103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
